Shire plc

From WikiCorporates
Jump to navigation Jump to search

Shire is a Jersey-registered, Irish-headquartered specialty biopharmaceutical company, owned by Japan's Takeda Pharmaceutical Company Ltd since Jan.2019.
Shire is a neuroscience specialist, well-known for its products for Attention Deficit Hyperactivity disorderWikipedia-W.svg, such as Vyvanse, Lialda, and Adderall XR. The company‘s biggest market is the USA.

Corporate Political Engagement Rating:[1] Transparency International    B  

Company

Ownership

Structure

  • Shire Ltd, was Shire plc, OC Flag-Jersey.svg
    • Baxalta UK Ltd, [CH]
      • Shire Pharmaceuticals Ltd, [CH]
    • Shire Biotech UK Holdings Ltd, [CH]
    • Shire Investments & Finance (UK) Company, [CH]
    • Shire US Investments, [CH]
    • Lumena Pharma UK Ltd, [CH]

Timeline

May.2018 Takeda Pharmaceutical Company Ltd acquired Shire, after some weeks of haggling.[2] The acquisition completed in Jan.2019, at which point Shire was delisted and taken private.[3]

Articles

References

  1. ^ Corporate Political Engagement Index 2018. The new index of 104 multi-national companies, many of whom regularly meet with govt, has found nearly 75% are failing to adequately disclose how they engage with politicians. Only one company received the highest grade, with the average grade being "E" – representing poor standards in transparency. Transparency International UK, Nov.2018.
  2. ^ Takeda to hold talks over Shire deal. Alex Ralh, The Times, Apr.25.2018.
  3. ^ Takeda completes Shire acquisition. PharmaTimes, Jan.08.2019.